Medicare Enrolled

Dr. Scott Hubosky, M.D.

Urology Physician · Philadelphia, PA
Practice pattern: Interventional Cardiology — Practice focused on catheter-based cardiac procedures
Speaking/Promotional
833 CHESTNUT ST, Philadelphia, PA 19107
2159551000
In practice since 2006 (20 years)
NPI: 1669451605 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hubosky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hubosky? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hubosky

Dr. Scott Hubosky is an urology physician in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hubosky performed 946 Medicare services across 676 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hubosky received a total of $19,837 from 14 pharmaceutical and/or device companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hubosky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 50% volume in PA $19,837 industry payments

Medicare Practice Summary

Medicare Utilization ↗
946
Medicare services
Top 50% in PA for urology physician
676
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~47 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
184 $20 $180
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
138 $51 $190
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
121 $96 $2,493
Imaging guidance for procedure, 60 minutes or less
Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less.
95 $13 $30
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
63 $344 $1,971
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
49 $57 $700
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
49 $126 $880
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
29 $106 $350
Kidney and ureter imaging injection via new skin access
A procedure involving an injection to image the kidney and ureter through a new skin access point, using imaging guidance and radiologist review.
27 $65 $778
Endoscopic removal of ureter or kidney growth
A procedure to remove a growth from the ureter or kidney using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and remove the tissue.
26 $391 $2,617
Cystourethroscopy with ureteroscopy or pyeloscopy
A diagnostic procedure using an endoscope to examine the bladder, urethra, and ureter or kidney.
23 $205 $1,615
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
23 $52 $275
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
23 $42 $75
Kidney and ureter stent removal and replacement
A procedure to remove an existing stent from the kidney and ureter and insert a new one. The process is guided by fluoroscopic imaging and includes a radiologist's review.
18 $36 $1,389
Bladder/urethra growth removal via endoscope, 0.5-2.0 cm
This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters.
18 $136 $1,410
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $78 $275
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $30 $130
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
16 $109 $245
Endoscopic removal of kidney or ureter stone
A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone.
11 $144 $1,100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.5% high complexity
32.3% medium
41.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$19,837
Total received (2018-2024)
Avg $2,834/year across 7 years
Top 8% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
14
Companies
63
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11,055 (55.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,072 (35.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,711 (8.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$826
2023
$2,228
2022
$1,651
2021
$2,519
2020
$513
2019
$827
2018
$11,274

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$540
Calyxo, Inc.
$94
UROGEN PHARMA, INC.
$60
Corcept Therapeutics
$48
Smith+Nephew, Inc.
$32
COLOPLAST CORP
$30
Janssen Biotech, Inc.
$23
Top 3 companies account for 83.9% of 2024 payments
All-time payments by company (2018-2024) ›
C. R. Bard, Inc. & Subsidiaries
$11,055
Boston Scientific Corporation
$5,035
BOSTON SCIENTIFIC CORPORATION
$2,495
C. R. BARD, INC. & SUBSIDIARIES
$465
Calyxo, Inc.
$155
Myriad Genetic Laboratories, Inc.
$137
BAXTER HEALTHCARE
$124
Ambu Inc.
$119
Janssen Biotech, Inc.
$65
UROGEN PHARMA, INC.
$60
Corcept Therapeutics
$48
Smith+Nephew, Inc.
$32
COLOPLAST CORP
$30
ABBVIE INC.
$19
Top 3 companies account for 93.7% of all-time payments
Associated products mentioned in payments ›
BOTOX · CVAC · CVAC ASPIRATION SYSTEM · Coloplast TFL Drive · ENDOBEAM · ERLEADA · FLOSEAL · GENERAL KIDNEY STONE DISEASE · GENERAL - KIDNEY STONE DISEASE · GENERAL KIDNEY STONE DISEASE · General - Kidney Stone Disease · INLAY · INLAY OPTIMA · JELMYTO · Korlym · LITHOVUE · LithoVue · PROLARIS · STRAVIX · SWISS LITHOCLAST TRILOGY · SpaceOAR VUE System - 10mL
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (56%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for urology physician in PA.

Looking for an urology physician in Philadelphia?
Compare urology physicians in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
297
Per 100K population
18.8
County median income
$60,698
Nearest hospital
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hubosky is an interventional cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 8% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hubosky experienced with imaging of urinary tract with contrast?
Based on Medicare claims data, Dr. Hubosky performed 184 imaging of urinary tract with contrast services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hubosky receive payments from pharmaceutical companies?
Yes. Dr. Hubosky received a total of $19,837 from 14 companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hubosky's costs compare to other urology physicians in Philadelphia?
Dr. Hubosky's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hubosky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →